257 related articles for article (PubMed ID: 12650610)
1. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter.
Denhardt DT; Mistretta D; Chambers AF; Krishna S; Porter JF; Raghuram S; Rittling SR
Clin Exp Metastasis; 2003; 20(1):77-84. PubMed ID: 12650610
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of human osteopontin promoter by C/EBPalpha and AML-1 in metastatic cancer cells.
Liu YN; Kang BB; Chen JH
Oncogene; 2004 Jan; 23(1):278-88. PubMed ID: 14712233
[TBL] [Abstract][Full Text] [Related]
3. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.
Guo X; Zhang YP; Mitchell DA; Denhardt DT; Chambers AF
Mol Cell Biol; 1995 Jan; 15(1):476-87. PubMed ID: 7799957
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
[TBL] [Abstract][Full Text] [Related]
6. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
Chambers AF; Hota C; Prince CW
Cancer Res; 1993 Feb; 53(3):701-6. PubMed ID: 8425206
[TBL] [Abstract][Full Text] [Related]
7. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Behrend EI; Wilson SM; Denhardt DT
Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
[TBL] [Abstract][Full Text] [Related]
8. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior.
Mi Z; Guo H; Wai PY; Gao C; Wei J; Kuo PC
J Biol Chem; 2004 Nov; 279(45):46659-67. PubMed ID: 15347645
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Identification of positive and negative regulatory elements and a 'silent' second promoter.
Zhang Q; Wrana JL; Sodek J
Eur J Biochem; 1992 Jul; 207(2):649-59. PubMed ID: 1633816
[TBL] [Abstract][Full Text] [Related]
10. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme.
Feng B; Rollo EE; Denhardt DT
Clin Exp Metastasis; 1995 Nov; 13(6):453-62. PubMed ID: 7586803
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the osteopontin promoter affect its transcriptional activity.
Giacopelli F; Marciano R; Pistorio A; Catarsi P; Canini S; Karsenty G; Ravazzolo R
Physiol Genomics; 2004 Dec; 20(1):87-96. PubMed ID: 15479859
[TBL] [Abstract][Full Text] [Related]
13. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
14. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
15. Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.
Wai PY; Mi Z; Gao C; Guo H; Marroquin C; Kuo PC
J Biol Chem; 2006 Jul; 281(28):18973-82. PubMed ID: 16670084
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4.
El-Tanani M; Barraclough R; Wilkinson MC; Rudland PS
Cancer Res; 2001 Jul; 61(14):5619-29. PubMed ID: 11454716
[TBL] [Abstract][Full Text] [Related]
17. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.
Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF
Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346
[TBL] [Abstract][Full Text] [Related]
18. Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.
Higashibata Y; Sakuma T; Kawahata H; Fujihara S; Moriyama K; Okada A; Yasui T; Kohri K; Kitamura Y; Nomura S
J Bone Miner Res; 2004 Jan; 19(1):78-88. PubMed ID: 14753740
[TBL] [Abstract][Full Text] [Related]
19. Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis.
Hartl M; Karagiannidis AI; Bister K
Oncogene; 2006 Jul; 25(29):4043-55. PubMed ID: 16491116
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
